Aspira Pathlab & Diagnostics Ltd — Important, 12-02-2026: Company Update

Aspira Pathlab & Diagnostics Limited's financial results for the quarter and nine months ended December 31, 2025, were approved at a board meeting held on February 10, 2026. For the quarter, the company reported revenue from operations of ₹5.12 Cr but recorded a net loss after tax of ₹1.56 Cr. Over the nine-month period, revenue from operations reached ₹18.46 Cr, with a net profit after tax of ₹0.74 Cr. This update offers key insights into the company's financial performance.